🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Jack Lawler

Beth Israel Deaconess Medical Center

ORCID: 0000-0001-5831-0982

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

3in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 5 papers. Top paper: “Thrombospondin‐1 as an endogenous inhibitor of angiogenesis and tumor growth”.

Thrombospondin‐1 as an endogenous inhibitor of angiogenesis and tumor growth

Journal of Cellular and Molecular Medicine(2002)10.1111/j.1582-4934.2002.tb00307.x

N/A

0.946DataRank · unranked

549 citations

Jack Lawler

Thrombospondin‐4 is expressed by early osteogenic tissues in the chick embryo

Developmental Dynamics(1995)10.1002/aja.1002030410

N/A

0.631DataRank · unranked

66 citations

Josephine C. Adams, Jack Lawler, Richard P. Tucker

Purification and Analysis of Thrombospondin‐1

Current Protocols in Cell Biology(2003)10.1002/0471143030.cb1010s17

N/A

0.208DataRank · unranked

3 citations

Mark Duquette, Anna Ludlow, Jack Lawler, Karen O. Yee

Single-cell analysis reveals a universal pericyte signature associated with poor clinical outcome and immune T cell dysfunction in thyroid cancer and other cancers

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.64898/2025.12.07.692700

N/A

0DataRank · unranked

0 citations

Yubin Na, Jack Lawler, Carmelo Nucera, A. Bhasin, Y. J Na +1 more

The Tyrosine Kinase Inhibitor Lenvatinib Inhibits Anaplastic Thyroid Carcinoma Growth by Targeting Pericytes in the Tumor Microenvironment

Thyroid(2023)10.1089/thy.2022.0597

N/A

0DataRank · unranked

11 citations

Stephanie Li, Peter M. Sadow, Mohammadreza Abbasian, Ara Nazarian, Jack Lawler +2 more